| Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings J Gea, S Pascual, C Casadevall, M Orozco-Levi, E Barreiro Journal of thoracic disease 7 (10), E418, 2015 | 229 | 2015 |
| Oxidative stress, redox signaling pathways, and autophagy in cachectic muscles of male patients with advanced COPD and lung cancer E Puig-Vilanova, DA Rodriguez, J Lloreta, P Ausin, S Pascual-Guardia, ... Free Radical Biology and Medicine 79, 91-108, 2015 | 177 | 2015 |
| Redox balance and carbonylated proteins in limb and heart muscles of cachectic rats J Marin-Corral, CC Fontes, S Pascual-Guardia, F Sanchez, M Olivan, ... Antioxidants & redox signaling 12 (3), 365-380, 2010 | 95 | 2010 |
| Respiratory diseases and muscle dysfunction J Gea, C Casadevall, S Pascual, M Orozco-Levi, E Barreiro Expert review of respiratory medicine 6 (1), 75-90, 2012 | 82 | 2012 |
| Metabolic signatures associated with severity in hospitalized COVID-19 patients J Marín-Corral, J Rodríguez-Morató, A Gomez-Gomez, S Pascual-Guardia, ... International journal of molecular sciences 22 (9), 4794, 2021 | 73 | 2021 |
| Oral low-dose theophylline on top of inhaled fluticasone-salmeterol does not reduce exacerbations in patients with severe COPD: a pilot clinical trial BG Cosío, H Shafiek, A Iglesias, A Yanez, R Córdova, A Palou, ... Chest 150 (1), 123-130, 2016 | 61 | 2016 |
| Vastus lateralis fiber shift is an independent predictor of mortality in chronic obstructive pulmonary disease MS Patel, SA Natanek, G Stratakos, S Pascual, J Martínez-Llorens, ... American journal of respiratory and critical care medicine 190 (3), 350-352, 2014 | 60 | 2014 |
| Negative immune responses to two-dose mRNA COVID-19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring M Crespo, A Barrilado-Jackson, E Padilla, J Eguía, D Echeverria-Esnal, ... American Journal of Transplantation 22 (3), 786-800, 2022 | 44 | 2022 |
| Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre study S Pascual, J Feimer, A De Soyza, J Sauleda Roig, J Haughney, ... NPJ primary care respiratory medicine 25 (1), 1-7, 2015 | 41 | 2015 |
| Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients L Millares, S Pascual, C Montón, M García-Núñez, C Lalmolda, R Faner, ... BMC Pulmonary Medicine 19, 1-9, 2019 | 40 | 2019 |
| Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point … M Carugati, S Aliberti, G Sotgiu, F Blasi, A Gori, R Menendez, M Encheva, ... European Journal of Clinical Microbiology & Infectious Diseases 39, 1513-1525, 2020 | 36 | 2020 |
| Structural differences in the diaphragm of patients following controlled vs assisted and spontaneous mechanical ventilation J Marin-Corral, I Dot, M Boguñá, L Cecchini, A Zapatero, MP Gracia, ... Intensive Care Medicine 45, 488-500, 2019 | 35 | 2019 |
| Clinical management of chronic obstructive pulmonary disease patients with muscle dysfunction J Gea, C Casadevall, S Pascual, M Orozco-Levi, E Barreiro Journal of thoracic disease 8 (11), 3379, 2016 | 32 | 2016 |
| Aspiration risk factors, microbiology, and empiric antibiotics for patients hospitalized with community-acquired pneumonia J Marin-Corral, S Pascual-Guardia, F Amati, S Aliberti, JR Masclans, ... Chest 159 (1), 58-72, 2021 | 31 | 2021 |
| The phosphodiesterase-4 inhibitor roflumilast reverts proteolysis in skeletal muscle cells of patients with COPD cachexia E Barreiro, E Puig-Vilanova, A Salazar-Degracia, S Pascual-Guardia, ... Journal of Applied Physiology 125 (2), 287-303, 2018 | 28 | 2018 |
| Hospital admissions and mortality in patients with COPD exacerbations and vertebral body compression fractures S Pascual-Guardia, D Badenes-Bonet, C Martin-Ontiyuelo, F Zuccarino, ... International journal of chronic obstructive pulmonary disease, 1837-1845, 2017 | 28 | 2017 |
| Immunologic resilience and COVID-19 survival advantage GC Lee, MI Restrepo, N Harper, MS Manoharan, AM Smith, JA Meunier, ... Journal of Allergy and Clinical Immunology 148 (5), 1176-1191, 2021 | 27 | 2021 |
| Non-typeable Haemophilus influenzae–Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised … S Andreas, M Testa, L Boyer, G Brusselle, W Janssens, E Kerwin, A Papi, ... The Lancet Respiratory Medicine 10 (5), 435-446, 2022 | 26 | 2022 |
| Health care-associated infections in patients with COVID-19 pneumonia in COVID critical care areas J Marin-Corral, S Pascual-Guardia, R Muñoz-Bermúdez, ... Medicina intensiva 46 (4), 221, 2022 | 23 | 2022 |
| Phenotypic characterisation of early COPD: a prospective case–control study BG Cosío, S Pascual-Guardia, A Borras-Santos, G Peces-Barba, S Santos, ... ERJ Open Research 6 (4), 2020 | 23 | 2020 |
